share_log

华润医药(03320):华润博雅生物前三季度净利润约4.12亿元,同比减少13.01%

Chinare Pharma (03320): China Resources Boya Bio-pharmaceutical Group's net income in the first three quarters was approximately 0.412 billion yuan, a decrease of 13.01% year-on-year.

Zhitong Finance ·  Oct 24, 2024 19:01

China Resources Pharmaceutical (03320) announced China Resources Boya Biotech's results for the first 9 months of 2024, with a total revenue of about 12.4...

According to the Zhitong Finance App, China Resources Pharmaceutical (03320) announced China Resources Pharmaceutical Biotech's results for the first nine months of 2024. Total operating revenue was about 1.245 billion yuan, a year-on-year decrease of 43.16%; net profit was about 0.412 billion yuan, a decrease of 13.01% year on year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment